Network pharmacology-based identification of key pharmacological pathways of epimedium acting on hepatocellular carcinoma
Authors:
- Mei YanMYMei Yan
- Guanping LaiGLGuanping Lai
- Renzhong XiaoRXRenzhong Xiao
Open Access
- 8 April 2025
- journal article
- Published by Elsevier in Chinese Journal of Analytical Chemistry
- Vol. 53 (6)
Abstract
No abstract availableFunding Information
- Jinhua City Science and Technology Bureau (2023KY06)
This publication has 38 references indexed in Scilit:
- Enhancing oxidant and dye scavenging through MgO-based chitosan nanoparticles for potential antioxidant coatings and efficient photocatalystsBiomass Conversion and Biorefinery, 2023
- Kaempferol inhibits the cell migration of human hepatocellular carcinoma cells by suppressing MMP‐9 and Akt signalingEnvironmental Toxicology, 2021
- Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma ProgressionACS Central Science, 2021
- Discovery of novel akt1 inhibitor induces autophagy associated death in hepatocellular carcinoma cellsEuropean Journal of Medicinal Chemistry, 2020
- Luteolin synergizes the antitumor effects of 5-fluorouracil against human hepatocellular carcinoma cells through apoptosis induction and metabolismLife Sciences, 2016
- Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells—A SAR studyBioorganic & Medicinal Chemistry Letters, 2014
- Physicochemical Space for Optimum Oral Bioavailability: Contribution of Human Intestinal Absorption and First-Pass EliminationJournal of Medicinal Chemistry, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Prediction of ‘drug-likeness’Advanced Drug Delivery Reviews, 2002
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001